Your browser doesn't support javascript.
loading
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions.
Alligier, Maud; Barrès, Romain; Blaak, Ellen E; Boirie, Yves; Bouwman, Jildau; Brunault, Paul; Campbell, Kristina; Clément, Karine; Farooqi, I Sadaf; Farpour-Lambert, Nathalie J; Frühbeck, Gema; Goossens, Gijs H; Hager, Jorg; Halford, Jason C G; Hauner, Hans; Jacobi, David; Julia, Chantal; Langin, Dominique; Natali, Andrea; Neovius, Martin; Oppert, Jean Michel; Pagotto, Uberto; Palmeira, Antonio L; Roche, Helen; Rydén, Mikael; Scheen, André J; Simon, Chantal; Sorensen, Thorkild I A; Tappy, Luc; Yki-Järvinen, Hannele; Ziegler, Olivier; Laville, Martine.
Affiliation
  • Alligier M; FCRIN/FORCE Network, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Lyon, France.
  • Barrès R; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Blaak EE; Department of Human Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Boirie Y; University Clermont Auvergne, CHU Clermont-Ferrand, Clinical Nutrition Department, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.
  • Bouwman J; TNO (Netherlands Organization for Applied Scientific Research), Microbiology and Systems Biology, Zeist, The Netherlands.
  • Brunault P; Equipe de Liaison et de Soins en Addictologie, CHRU de Tours, and UMR 1253, iBrain, Université de Tours, Inserm, and Qualipsy EE 1901, Université de Tours, Tours, France.
  • Campbell K; KC Microbiome Communications Group, Victoria, British Columbia, Canada.
  • Clément K; Sorbonne University/INSERM, Nutrition and Obesities, Systemic Approaches Research Unit, and Assistance Publique Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière Hospital, Paris, France.
  • Farooqi IS; Wellcome-MRC Institute of Metabolic Science and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Farpour-Lambert NJ; Obesity Prevention and Care Program Contrepoids, Service of Therapeutic Education for Chronic Diseases, Department of Community Health, Primary Care and Emergency, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
  • Frühbeck G; Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, University of Navarra & CIBEROBN, IdiSNA, Pamplona, Spain.
  • Goossens GH; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Hager J; Metabolic Phenotyping, Nestlé Institute of Health Sciences, Lausanne, Switzerland.
  • Halford JCG; Psychological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Hauner H; Institute of Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Jacobi D; L'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes, France.
  • Julia C; Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center (CRESS), Inra, Cnam, Paris 13 University and Public Health Department, Avicenne Hospital, AP-HP, Bobigny, France.
  • Langin D; Institute of Metabolic and Cardiovascular Diseases, I2MC, Inserm, Paul Sabatier University, and Department of Medical Biochemistry, Toulouse University Hospitals, Toulouse, France.
  • Natali A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Neovius M; Department of Medicine (Solna), Karolinska Institute, Stockholm, Sweden.
  • Oppert JM; Department of Nutrition, Pitié-Salpêtrière Hospital (AP-HP), Sorbonne University, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
  • Pagotto U; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Policlinic S. Orsola, Endocrinology Unit, Bologna, Italy.
  • Palmeira AL; CIPER, PANO-SR, Faculty of Human Kinetics, University of Lisbon, Lisbon, Portugal.
  • Roche H; Nutrigenomics Research Group, UCD Institute of Food & Health, University College Dublin, Dublin, Ireland.
  • Rydén M; Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Scheen AJ; Liège University, Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liège, Liège, Belgium.
  • Simon C; CarMen Laboratory, INSERM 1060, INRA 1397, University of Lyon, Oullins, France.
  • Sorensen TIA; Novo Nordisk Foundation Center for Basic Metabolic Research, and Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Tappy L; Physiology Department, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Yki-Järvinen H; University of Helsinki, Helsinki University Hospital, and Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Ziegler O; Department of Endocrinology, Diabetes and Nutrition, Hôpital Brabois Adultes, CHRU de Nancy, Vandoeuvre Lès Nancy, France.
  • Laville M; FCRIN/FORCE Network, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université de Lyon, Hospices Civils de Lyon, Lyon, France, martine.laville@univ-lyon1.fr.
Obes Facts ; 13(1): 1-28, 2020.
Article in En | MEDLINE | ID: mdl-31945762
ABSTRACT
Heterogeneity of interindividual and intraindividual responses to interventions is often observed in randomized, controlled trials for obesity. To address the global epidemic of obesity and move toward more personalized treatment regimens, the global research community must come together to identify factors that may drive these heterogeneous responses to interventions. This project, called OBEDIS (OBEsity Diverse Interventions Sharing - focusing on dietary and other interventions), provides a set of European guidelines for a minimal set of variables to include in future clinical trials on obesity, regardless of the specific endpoints. Broad adoption of these guidelines will enable researchers to harmonize and merge data from multiple intervention studies, allowing stratification of patients according to precise phenotyping criteria which are measured using standardized methods. In this way, studies across Europe may be pooled for better prediction of individuals' responses to an intervention for obesity - ultimately leading to better patient care and improved obesity outcomes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Expert Testimony / Biological Variation, Population / Medical History Taking / Obesity Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Obes Facts Journal subject: METABOLISMO Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Expert Testimony / Biological Variation, Population / Medical History Taking / Obesity Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Obes Facts Journal subject: METABOLISMO Year: 2020 Document type: Article Affiliation country: